Detailed price information for Fibrobiologics Inc (FBLG-Q) from The Globe and Mail including charting and trades.
The first sock measuring shear stress aimed at reducing the risk of foot ulcers for patients with diabetes is among several innovations being ...
Lakewood-Amedex Biotherapeutics Inc., (NASDAQ: LABT) a clinical-stage biotechnology company advancing a novel class of potent ...
WRITTEN BY ANNE GABBIANELLI According to the American Podiatric Medical Association, at least 75% of Americans will ...
FibroBiologics Inc. FBLG on Monday released the first batch of its CYWC628 drug product to support its Phase 1/2 clinical ...
The U.S. Wound Cleanser Products Market is projected to grow from USD 0.99 Billion in 2025 to USD 1.49 Billion by 2035, as chronic wounds continue to rise and demand for advanced care ...
AOTI’s topical wound oxygen (TWO2) therapy study shows superior durable healing of chronic wounds in 3,126 patients: Oceanside, California Wednesday, April 29, 2026, 18:00 Hrs [ ...
Convatec, a leading medical products and technology company focused on chronic condition management, takes to the stage to showcase the breadth, depth and momentum behind its Advanced Wound Care ...
CMO Ray Turner discusses PriMatrix's non-cross-linked fetal bovine dermal matrix design, superior vascularization, and ...
Pharmakon Medical Research expands its clinical trial portfolio with five new wound care studies, advancing innovation ...
On track for first patient dosed in phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers in Q2 of 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results